Detalhe da pesquisa
1.
A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: Stage 2 of a phase II trial.
Haematologica
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268448
2.
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Haematologica
; 108(10): 2730-2742, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165840
3.
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors.
Invest New Drugs
; 39(6): 1587-1597, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34180037
4.
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemia.
Invest New Drugs
; 38(5): 1430-1441, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32020437
5.
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.
Invest New Drugs
; 38(4): 1156-1165, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31734832
6.
PHOTORECEPTOR INNER SEGMENT MORPHOLOGY IN BEST VITELLIFORM MACULAR DYSTROPHY.
Retina
; 37(4): 741-748, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27467379
7.
REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIA.
Retina
; 37(10): 1956-1966, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28145975
8.
Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients.
Br J Cancer
; 114(6): 616-22, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26889973
9.
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.
Nature
; 467(7315): 596-9, 2010 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20823850
10.
A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancer.
Support Care Cancer
; 23(6): 1669-77, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25421443
11.
Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy.
Bioorg Med Chem
; 22(15): 4001-9, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997575
12.
Longitudinal Assessment of OCT-Based Measures of Foveal Cone Structure in Achromatopsia.
Invest Ophthalmol Vis Sci
; 65(4): 16, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587442
13.
In Vivo Assessment of Retinal Phenotypes in Axenfeld-Rieger Syndrome.
Invest Ophthalmol Vis Sci
; 65(4): 20, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587439
14.
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease.
Nat Commun
; 15(1): 651, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246924
15.
Assessing the Sensitivity of OCT-A Retinal Vasculature Metrics.
Transl Vis Sci Technol
; 12(8): 2, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531114
16.
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.
Cancer Cell
; 2(2): 127-37, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12204533
17.
Event Medicine: Pearls and pitfalls of managing mass gatherings.
JEMS
; 42(5): 36-43, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29227598
18.
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study.
Blood Adv
; 6(4): 1162-1174, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34933330
19.
MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer.
Mol Cancer
; 10: 49, 2011 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21539745
20.
Automated image processing pipeline for adaptive optics scanning light ophthalmoscopy.
Biomed Opt Express
; 12(6): 3142-3168, 2021 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34221651